Milligan Sandra 4
4 · Spyre Therapeutics, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Milligan Sandra
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-14+21,980→ 21,980 totalExercise: $39.29Exp: 2034-05-14→ Common Stock (21,980 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 21,980 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments following May 14, 2024 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.